- Home
- BANC vs VCYT Comparison
BANC vs VCYT Comparison
Compare BANC & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANC | VCYT |
|---|---|---|
| Founded | 1941 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | BANC | VCYT |
|---|---|---|
| Price | $19.94 | $43.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | $20.06 | ★ $45.38 |
| AVG Volume (30 Days) | ★ 2.0M | 959.1K |
| Earning Date | 01-22-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.03 | 0.38 |
| Revenue | ★ $1,019,965,000.00 | $495,141,000.00 |
| Revenue This Year | $4.33 | $16.02 |
| Revenue Next Year | $14.27 | $10.74 |
| P/E Ratio | ★ $19.16 | $112.82 |
| Revenue Growth | ★ 147.22 | 16.41 |
| 52 Week Low | $11.52 | $22.61 |
| 52 Week High | $20.17 | $50.71 |
Technical Indicators
Market Signals| Indicator | BANC | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 69.51 | 51.20 |
| Support Level | $19.60 | $41.32 |
| Resistance Level | $20.07 | $43.82 |
| Average True Range (ATR) | 0.40 | 1.72 |
| MACD | -0.01 | -0.50 |
| Stochastic Oscillator | 74.48 | 27.73 |
Price Performance
Historical ComparisonAbout BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.